Business: Solventum, formerly known as 3M Health Care, is a global health-care company that was spun out from 3M on April 1. It has four main segments. First, there is Medical Surgical, a provider of ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Solventum, the recently spun off healthcare arm of 3M, faces challenges in value creation due to stagnant growth, heavy debt burden, and entanglement with its former parent. The company's revenue ...
Trian Fund Management, which beneficially owns ~5% of Solventum Corporation (SOLV) and is the company’s largest active shareholder, released an open letter and slide deck outlining its views on ...
Hosted on MSN
Solventum (NYSE:SOLV) exceeds Q1 CY2026 expectations
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q1 CY2026 results , but sales fell by 3% year on year to $2.01 billion. Its non-GAAP profit of $1.48 per share was 9.3% above analysts’ ...
Hosted on MSN
Solventum stock is recovering: What's going on?
Solventum Corp SOLV shares are rebounding on Thursday after activist investor Trian Fund Management released a sharply worded open letter criticizing the company's post‑spin performance and urging the ...
Solventum has a few good businesses, but the market is treating it as a complicated company. Its main parts are MedSurg, Dental, HIS, and a smaller Water / All Other. The thesis says the stock looks ...
Solventum SOLV reported first-quarter 2025 adjusted earnings per share (EPS) of $1.34, which beat the Zacks Consensus Estimate of $1.19 by 12.6%. The bottom line declined 35.6% year over year. GAAP ...
Analysts are changing their tune on Solventum as 2025 comes to a close, as analysts at BTIG upgrade the company to “buy” in the final month of the year. Solventum has spent the last year routinely ...
Feb 26 (Reuters) - Medical device maker Solventum (SOLV.N), opens new tab on Thursday beat Wall Street estimates for the fourth quarter, helped by strong demand for its wound care and sterilization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results